EPIGLO PHARMACEUTICALS
Supplier Forensic Analysis · Scanned: 2026/07/29
Open this supplier in the workbench →These findings identify statistical unusualness and named data patterns for review. They do not establish wrongdoing and require source verification.
CIPC screening
ClearCompliance
N/A/100
Awards
4
Total Value
R 461M
Recent Awards
4 awards · Total: R 460 774 764,47
HP07-2026DAI: Supply and Delivery of Pharmaceutical Products: Drops, Aerosols and Inhaled Medicines to the Department of Health for the period 01 September 2026 to 31 August 2029
Health and Welfare Sector Education and Training Authority
Ref: HP07-2026DAIR 22 328 694,74
22 Jun 2026
Supply and delivery of bandages and dressing to the State for the period of sixty (60) months
National Treasury
Ref: RT42-2025R 204,51
10 Nov 2025
HP02-2025AI: Supply and Delivery of Anti-Infective Medicines (Antibiotics, Antifungal, Antiprotozoal and Antiviral Agents) to the Department of Health for the period 1 October 2025 to 30 September 2028.
Health
Ref: HP02-2025AIR 320 395 855,36
21 Aug 2025
Supply and Delivery of Anti-Infective Medicines (Antibiotics, Antifungal, Antiprotozoal and Antiviral Agents) to the Department of Health for the period 1 October 2023 to 30 September 2025
Health
Ref: HP02-2023AIR 118 050 009,86
15 Jun 2023
AI Analysis
Powered by GeminiAI Forensic Analysis
Get AI-generated audit narratives with key findings and recommended actions.
Paid access from R499/mo
or upgrade to Pro Subscription
Procurement context
Competitive concentration, procurement-intelligence context, province health, and restricted-supplier status are available to forensic subscribers.
Unlock forensic context →CIPC screening signalsClear
No contributing warning signals in the current evidence.
Unlock Full Analysis
Get access to all forensic flags, evidence details, and AI-generated audit narratives.
View Full Intelligence Report
Get complete award history, director network, and compliance analysis.
View Report →